GE Healthcare Life Sciences Launches New Software for Cell Therapy Workflow
The new software lets users choose the volume and cell concentration from initial cell preparation through transduction to final resuspension, without compromising cell viability and virus stability.
GE Healthcare Life Sciences announced the launch of its SpinOculation C-Pro Protocol Software for cell therapy workflow on Dec. 2, 2019.
The new software is part of the Sepax C-Pro Cell Processing System and, when used with the Sepax C-Pro instrument and CT-60.1 single-use kit, lets users choose the volume and cell concentration from initial cell preparation through transduction to final resuspension, without compromising cell viability and virus stability, according to a company press release. The software also closes and automates the cell transduction step, reduces manipulations, and adjusts open system parameters.
“Cell-therapy manufacturing is complex and requires advanced technologies,” said Catarina Flyborg, general manager, Cell and Gene Therapy, GE Healthcare Life Sciences, in the press release. “GE Healthcare Life Sciences continues to invest and develop the digital solutions needed to advance cell and gene therapies. The SpinOculation C-Pro software application automates and simplifies a critical step in the cell therapy workflow and helps accelerate the development of next generation therapeutics.”
The SpinOculation C-Pro Protocol Software is now available worldwide.
Source: GE Healthcare Life Sciences
Entering New Domains for 3D Printing of Drug Products
April 6th 20253D printing of personalized medications is currently possible under existing compounding regulations, offering enhanced process control through automation. But new legislation coming in 2025 will allow 3D printing as part of a distributed manufacturing framework.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
